https://www.israelnationalnews.com/news/319067
Assuta Hospital in Ashdod has published a new groundbreaking research showing that the booster dose of the COVID-19 vaccine increases by 40 times the number of antibodies found in immunocompromised patients.
Recent research from around the world has shown a drop in the number of antibodies starting a few months after the second dose, alongside an extreme and encouraging rise following the administration of a booster dose in the general population.
The Assuta research shows that this data holds true for those who are immunocompromised as well.
That's today's study. tomorrow it'll be that the new boost doesn't do anything.
ReplyDelete